The world of patient care is constantly evolving, thanks to the hard work, continuous innovation, and collaborative spirit of doctors, international healthcare providers, patient advocacy groups, and governments. To showcase some of the latest developments in this sector and their potential benefits for Taiwanese patients, AmCham Taiwan and the American Institute in Taiwan jointly held…

For multinational pharmaceutical companies, Taiwan has proven itself to be a very attractive investment destination in the Asia Pacific. The island’s sizeable pool of high-quality STEM talent, its extensive expertise in and productive environment for conducting clinical trials, active government-industry-academia cooperation in medical research, and advanced bio-ICT capacity are just a few of the qualities…

The use of artificial intelligence (AI) technologies in critical care has potentially lifesaving outcomes for long-term disease prevention and critical decisions during surgery. AI technologies can help medical professionals find biomarkers of disease, identify target molecules, discover drug candidates, speed up clinical trials, and even monitor and predict epidemic outbreaks. There is also a distinct…

The island’s effective management of the pandemic has helped boost its attractiveness as a destination for international healthcare companies to conduct clinical trials of new drugs. But to remain competitive post-COVID, Taiwan may need to take some additional steps. Within the global healthcare industry, one of the areas in which the COVID-19 pandemic has had…

In the 60 years since Pfizer set up its first factory in Taiwan, the company has relentlessly pursued life-changing pharmaceutical and biotechnological breakthroughs. The company’s most important accomplishment in Taiwan, however, is its contribution to improving patients’ quality of life through the introduction to the market of the most advanced, innovative drugs, notes Country Manager…

After nearly two years, COVID-19 continues to impact countries around the world. The pandemic has also highlighted the vital role of healthcare companies in developing and ensuring the equitable distribution of life-saving medicines.   Among those involved in the effort to stop the spread and negative effects of coronavirus is global pharmaceutical firm Merck, Sharp, and…

AmCham Taiwan’s 2021 Healthcare Innovation Forum was held on October 25 at the Shangri-La’s Far Eastern Plaza Hotel, drawing an audience of 80 members and their guests. The Chamber was honored to gather industry leaders and experts in tech, innovation, and healthcare fields to explore the possibilities afforded by smart healthcare. Opening remarks at the…

BoonHuey Ee, general manager of Merck Healthcare Taiwan, Hong Kong, and Macau, is a Merck veteran with more than two decades’ experience in the healthcare industry. Ee has acquired in-depth knowledge of local and regional markets and had extensive exposure to various complex healthcare environments from her various managerial roles across the Asia-Pacific region. As…

While Taiwan has seen a surge in the adoption of telemedicine in recent months, its utilization rate of home-based dialysis is less than half that of the Asia Pacific average. The COVID-19 pandemic has accelerated the digitalization of healthcare and increased the market for telemedicine. As a result of capacity-saving efforts and swift innovation during…